2711a Objectives Positive serum antithyroglobulin antibody (TgAb) can be used as a
surrogate marker of persistent or recurrent disease (PRD), which remains controversial in …

Purpose Postoperative thyroglobulin (Tg) generally serves as a biomarker to monitor the
recurrence or persistence of differentiated thyroid cancer (DTC), whereas it constrains to …

1257 Objectives Clinical significance of circulating anti-thyroglobulin antibody (TgAb) titers
during the follow-up of differenciated thyroid cancer (DTC) was not well demonstrated. To …

Objective: To analyze the association between thyroglobulin antibody (TgAb) and
differentiated thyroid cancer (DTC) metastases detected by post-radioactive iodine (RAI) …

Objective Antithyroglobulin antibody (TgAb) is a potential tumour marker for detecting
differentiated thyroid cancer (DTC) recurrence, but insufficient data have supported its …

Background and Purpose This study aimed to analyze the diagnostic ability of the
combination of stimulated thyroglobulin (sTg) and antithyroglobulin antibody (TgAb) in …

Context The coexistence of differentiated thyroid cancer (DTC) and thyroid autoimmune
disease could represent a better or worse prognosis. This study investigated the prognostic …

Background In the period immediately following thyroidectomy for differentiated thyroid
cancer, there is a need to determine the extent of persistent disease and the likelihood of …

2988 Introduction: To identify predictive factors of post-operative thyroglobulin (Tg)< 0.2
ng/ml and pre-ablation stimulated Tg (s-Tg)> 10 ng/ml in differentiated thyroid carcinoma …

1936 Objectives We aimed to investigate the added value of presence of high serum anti-
thyroglobulin antibody levels in the postoperative work-up of patients with differentiated …